Shanghai Xuerong Bio-Technology Co Ltd (300511) - Cash Flow Conversion Efficiency

Latest as of June 2023: -0.036x

Based on the latest financial reports, Shanghai Xuerong Bio-Technology Co Ltd (300511) has a cash flow conversion efficiency ratio of -0.036x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-62.35 Million ≈ $-9.12 Million USD) by net assets (CN¥1.71 Billion ≈ $250.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check Shanghai Xuerong Bio-Technology Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Shanghai Xuerong Bio-Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Shanghai Xuerong Bio-Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. See Shanghai Xuerong Bio-Technology Co Ltd shareholders equity for net asset value and shareholders' equity analysis.

Shanghai Xuerong Bio-Technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Xuerong Bio-Technology Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Globalworth REIT
LSE:GWI
0.022x
Beijing Mainstreets Investment
SHE:000609
-1.667x
Guizhou Transp Planning
SHG:603458
0.028x
Gyre Therapeutics Inc.
NASDAQ:GYRE
0.034x
Ibotta, Inc.
NYSE:IBTA
0.066x
Hyulim ROBOT Co.Ltd
KQ:090710
-0.070x
Pareto Bank ASA
OL:PARB
-0.015x
Sichuan Kexin Mechanic Electric
SHE:300092
0.018x

Annual Cash Flow Conversion Efficiency for Shanghai Xuerong Bio-Technology Co Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Shanghai Xuerong Bio-Technology Co Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Shanghai Xuerong Bio-Technology Co Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥823.32 Million
≈ $120.48 Million
CN¥437.20 Million
≈ $63.98 Million
0.531x +112.56%
2023-12-31 CN¥1.43 Billion
≈ $209.60 Million
CN¥357.84 Million
≈ $52.36 Million
0.250x +10.63%
2022-12-31 CN¥1.63 Billion
≈ $237.91 Million
CN¥367.13 Million
≈ $53.72 Million
0.226x +51.42%
2021-12-31 CN¥1.65 Billion
≈ $242.11 Million
CN¥246.75 Million
≈ $36.11 Million
0.149x -45.69%
2020-12-31 CN¥2.02 Billion
≈ $296.00 Million
CN¥555.47 Million
≈ $81.28 Million
0.275x -18.60%
2019-12-31 CN¥1.74 Billion
≈ $254.60 Million
CN¥586.93 Million
≈ $85.89 Million
0.337x +30.18%
2018-12-31 CN¥1.57 Billion
≈ $229.73 Million
CN¥406.82 Million
≈ $59.53 Million
0.259x +11.68%
2017-12-31 CN¥1.42 Billion
≈ $207.26 Million
CN¥328.64 Million
≈ $48.09 Million
0.232x -5.80%
2016-12-31 CN¥1.29 Billion
≈ $188.75 Million
CN¥317.71 Million
≈ $46.49 Million
0.246x -42.15%
2015-12-31 CN¥642.99 Million
≈ $94.09 Million
CN¥273.77 Million
≈ $40.06 Million
0.426x -11.06%
2014-12-31 CN¥529.00 Million
≈ $77.41 Million
CN¥253.24 Million
≈ $37.06 Million
0.479x -11.72%
2013-12-31 CN¥433.49 Million
≈ $63.43 Million
CN¥235.07 Million
≈ $34.40 Million
0.542x +84.31%
2012-12-31 CN¥381.15 Million
≈ $55.77 Million
CN¥112.14 Million
≈ $16.41 Million
0.294x --

About Shanghai Xuerong Bio-Technology Co Ltd

SHE:300511 China Farm Products
Market Cap
$570.16 Million
CN¥3.90 Billion CNY
Market Cap Rank
#11837 Global
#3504 in China
Share Price
CN¥6.08
Change (1 day)
-0.33%
52-Week Range
CN¥5.76 - CN¥8.24
All Time High
CN¥25.74
About

Shanghai Xuerong Biotechnology Co.,Ltd., together with its subsidiaries, engages in the research and development, cultivation and sale of fresh edible mushrooms in the People's Republic of China. It offers enoki mushrooms; shiitake mushrooms, including oyster mushrooms, white jade mushrooms and seafood mushrooms; king oyster mushrooms; and velvet mushrooms, as well as Pleurotus eryngii and Flammu… Read more